Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes

NCT04532346 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Interstitial Lung Disease
Surfactant Dysfunction

Interventions

DRUG: Hydroxychloroquine

Sponsor

Children's Hospital of Fudan University